These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1732522)
1. Muscarinic activity of the thiolactone, lactam, lactol, and thiolactol analogues of pilocarpine and a hypothetical model for the binding of agonists to the m1 receptor. Shapiro G; Floersheim P; Boelsterli J; Amstutz R; Bolliger G; Gammenthaler H; Gmelin G; Supavilai P; Walkinshaw M J Med Chem; 1992 Jan; 35(1):15-27. PubMed ID: 1732522 [TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes. Arnt J; Lembøl HL; Meier E; Pedersen H Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027 [TBL] [Abstract][Full Text] [Related]
3. SDZ ENS 163 a novel pilocarpine like drug: pharmacological in vitro and in vivo profile. Enz A; Boddeke H; Sauter A; Rudin M; Shapiro G Life Sci; 1993; 52(5-6):513-20. PubMed ID: 8382766 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity studies of a series of 1-oxa-8-azaspiro[4.5]decanes as M1 muscarinic agonists. Tsukamoto S; Fujii M; Yasunaga T; Matsuda K; Wanibuchi F; Hidaka K; Furuya T; Tamura T Chem Pharm Bull (Tokyo); 1995 May; 43(5):842-52. PubMed ID: 7553970 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular modeling studies, and muscarinic receptor activity of azaprophen analogues. Triggle DJ; Kwon YW; Abraham P; Pitner JB; Mascarella SW; Carroll FI J Med Chem; 1991 Nov; 34(11):3164-71. PubMed ID: 1956033 [TBL] [Abstract][Full Text] [Related]
14. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation. Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity studies of a series of spirooxazolidine-2,4-diones: 4-oxa analogues of the muscarinic agonist 2-ethyl-8-methyl-2,8-diazaspiro[4.5]decane-1,3-dione. Tsukamoto S; Ichihara M; Wanibuchi F; Usuda S; Hidaka K; Harada M; Tamura T J Med Chem; 1993 Aug; 36(16):2292-9. PubMed ID: 8360873 [TBL] [Abstract][Full Text] [Related]
16. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease. Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998 [TBL] [Abstract][Full Text] [Related]
17. The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo. Freedman SB; Dawson GR; Iversen LL; Baker R; Hargreaves RJ Life Sci; 1993; 52(5-6):489-95. PubMed ID: 8441329 [TBL] [Abstract][Full Text] [Related]
18. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors. Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595 [TBL] [Abstract][Full Text] [Related]